The problem
An estimated 50 million people worldwide have a chronic hepatitis C infection. People living with HIV are at greater risk from the virus, and chronic liver disease is a major cause of illness and death among people with HIV. Highly effective new medicines could revolutionize treatment but a lack of awareness about hepatitis C limits the potential of the drugs.
Download the project evaluation
Our response
Working with civil society partners, this project advocated at the government level to make hepatitis C care more available and inclusive and to implement new policies that address the needs of marginalized communities. Coalition PLUS also raised awareness of hepatitis C testing and treatment with a focus on approaches that target marginalized populations such as people who inject drugs, men who have sex with men and people in prisons to increase diagnosis, combat stigma and generate demand for treatment.
